Healthy sex lives require partners to align on sexual values and reach joint agreements. Avoiding sexual conversations leads ...

They promise clearer, younger-looking skin, but is your money better spent elsewhere? Dermatologists and experts weigh in ...

The guidelines would bolster Medicaid’s oversight of autism therapy, focusing on a growing business that is drawing scrutiny from federal investigators.

Ocular Therapeutix eyes a 2027 AXPAXLI launch for wet AMD/retinal disease with strong Phase 3 data, an FDA-aligned NDA in Q4 ...

Scientists are studying how the nervous system synchronizes with rhythm and sound, opening new possibilities for neurological ...

The Centers for Medicare and Medicaid Services has launched a state toolkit with resources on applied behavior analysis (ABA) therapy with the goal of helping states protect children with | The ...

Long-acting GLP-1 drug TE-8105, developed by Taiwan biotech Immunwork, confirmed a five-day plasma half-life in first-in-human trials using a dual fatty acid bundle approach not used by any approved ...

A prospective study led by researchers at Children's National found that onabotulinumtoxinA (ONA), commonly known as Botox, ...

Radiopharmaceutical therapy (RPT) has made significant strides over the past 50 years, although it only recently received FDA ...

The American College of Chest Physicians® (CHEST) recently released a new clinical guideline on the management of adult bronchiectasis. Published in the journal CHEST®, the guideline contains ...

ClearPoint Neuro's Q2 miss and preclinical delays weigh on 2026, but regulatory clarity boosts 2027-28 upside. Click to see ...

High-frequency, low-dose rituximab achieved ~85% peripheral CLL clearance within 1 hour and ~34% nodal reduction in 1 week, with macrophage phagocytosis and complement as dominant mechanisms.